Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/21593
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPaschou, S.en
dc.contributor.authorVoulgari, P. V.en
dc.contributor.authorVrabie, I. G.en
dc.contributor.authorSaougou, I. G.en
dc.contributor.authorDrosos, A. A.en
dc.date.accessioned2015-11-24T19:15:58Z-
dc.date.available2015-11-24T19:15:58Z-
dc.identifier.issn0315-162X-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/21593-
dc.rightsDefault Licence-
dc.subjectAdulten
dc.subjectAntibodies, Monoclonal/*adverse effectsen
dc.subjectAntirheumatic Agents/adverse effectsen
dc.subjectFertility/*drug effects/physiologyen
dc.subjectHumansen
dc.subjectInfertility/*chemically induceden
dc.subjectMaleen
dc.subjectReproduction/drug effects/physiologyen
dc.subjectSpermatogenesis/*drug effects/physiologyen
dc.subjectSpermatozoa/drug effects/physiologyen
dc.subjectSpondylitis, Ankylosing/*drug therapyen
dc.subjectTumor Necrosis Factor-alpha/antagonists & inhibitorsen
dc.titleFertility and reproduction in male patients with ankylosing spondylitis treated with infliximaben
heal.typejournalArticle-
heal.type.enJournal articleen
heal.type.elΆρθρο Περιοδικούel
heal.identifier.primary10.3899/jrheum.080554-
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/19040305-
heal.languageen-
heal.accesscampus-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.publicationDate2009-
heal.abstractOBJECTIVE: To identify male patients who were treated with infliximab and had fathered healthy newborns during their management. METHODS: We reviewed medical records of men with ankylosing spondylitis (AS) who were followed up at the Rheumatology Outpatients clinic and were treated with infliximab during the period 2001-2007. RESULTS: We identified 4 patients with AS who had fathered 6 healthy children during infliximab treatment. One patient was also treated with small doses of methotrexate. CONCLUSION: Limited data are available concerning the effects of infliximab on semen quality. Our cases provide some evidence or reassurance for male patients treated with the anti-tumor necrosis factor-alpha agent. Further prospective studies are necessary, however, to guide clinicians in decision making.en
heal.journalNameJ Rheumatolen
heal.journalTypepeer-reviewed-
heal.fullTextAvailabilityTRUE-
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ

Files in This Item:
There are no files associated with this item.


This item is licensed under a Creative Commons License Creative Commons